Webinars

As drug modalities evolve in complexity with multiplexed mechanisms of action, the need for frequent sampling of patients to monitor the safety and efficacy becomes…

Oncolytic viruses for the treatment of cancer and genetic disease has been an area of active study for decades. Testing strategies for monitoring efficacy and…

PK assays are a vital component of the drug development process and the data derived is utilized to help select the dosage for preclinical and…

Advanced modalities do not easily lend themselves to the standard approaches for quantitating drug product as small and large molecule therapeutics do. Watch Now

Technology platforms not typically used for regulated bioanalysis are now utilized more frequently to support cell and gene therapy programs. Flow cytometry, ELISpot and quantitative…

In association with Oxford Global, this webinar will highlight how to properly structure your program and get an in-depth look at the critical parameters needed…

The emergence of advanced therapeutic medicinal products (ATMPs), such as cell and gene therapies, has led to the increased utilization of specialized technology platforms in…

This webinar will provide an overview of considerations relevant to representative ATMPs in the development and lifecycle of assays for potency, purity, quantity, and identity…

In this eChalk Talk, we will discuss the different platforms that are used to evaluate the immunogenicity of ATMPs including ligand binding assays, flow cytometry,…

In association with Bioanalysis Zone, this webinar will highlight how bioanalytical strategies for implementing biomarkers in clinical trials will be presented. Watch Now